Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 10-CC-0115 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Background:
- Magnetic resonance imaging (MRI) scans must be performed according to specified sets of parameters that provide optimal images of each organ and each area of the body. These scanning parameters are often specific to the institution or organization at which they are employed, and may also depend on the manufacturer of the MRI scanning equipment. Because MRI scanning equipment is always being updated and upgraded, researchers are interested in developing new and optimized scanning parameters for MRI scans.
Objectives:
- To improve current methods and develop new techniques for magnetic resonance imaging.
Eligibility:
Design:
Magnetic Resonance (MR) Imaging performed on volunteers will be used to develop and optimize techniques useful in the advancement of MRI technology.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Volunteers | Volunteers (maybe Volunteers, NIH employee and current NIH protocol participants) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To refine current methodology and develop new techniques for MRI | To refine current methodology and develop new techniques for magnetic resonance imaging in the general population. | End of study |
Not provided
Not provided
A. Volunteer individuals
B. Lab Eligibility parameters (for contrast scans within 4 weeks of gadolinium injection):
C. Creatinine below upper normal limit
D. eGFR >= 60 mL/min/1.73m2
E. Age >= 60 or history of renal disease: test GFR within 1 week prior to contrast
F. Willing to travel to the NIH for follow-up visits.
G. 18 years old
H. Able to understand and sign informed consent
I. No MRI scan with gadolinium injection in the last 6 months under this protocol.
EXCLUSION CRITERIA:
A. Implanted metal clips or wires of the type which may concentrate radiofrequency fields or cause tissue damages from twisting in a Magnetic field. Examples:
B. Pregnant women
C. Paralyzed hemidiaphragm
D. Over 500 lbs and/or a body circumference that prevents the study subject from laying flat in the scanner
E. Surgery of uncertain type
F. Untreatable claustrophobia otherwise requiring anesthesia.
G. Any contraindications that the Physician identifies from the subject, MRI Safety Questionnaire, and/or History and Physical.
EXCLUSION FOR PARTICIPANTS FOR GADOLINIUM CONTRAST:
(Inclusive of the above exclusion criteria):
A. Allergy to gadolinium for scans using contrast; will be eligible for non-contrast scans.
B. Acute renal failure, renal transplant, dialysis and renal failure individuals (eGFR <60 mL/min/1.73m2 and/or clinically diagnosed).
C. Individuals with a history of liver transplant or severe liver disease.
D. Lactating women
E. Individuals with hemoglobinopathies or severe asthma.
F. Patient preference to not undergo intravenous line placement and/or receive gadolinium contrast. Contrast administration is optional and participants may still undergo a non-contrast study.
G. GBCA with an MRI scan in the last 6 months. This includes scan performed with GBCA at any outside institution and / or at the clinical center .In addition, they cannot have reached their maximum of 4 GBCA imaging studies under this protocol. They will be excluded from having a contrast enhanced MRI, but will not be excluded from the protocol for non-contrast MRI studies.
Not provided
Not provided
Volunteers (maybe Volunteers, NIH employee and current NIH protocol participants)
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Tracy L Cropper, R.N. | Contact | (301) 402-6132 | tcropper@cc.nih.gov | |
| Bernadette A Redd, M.D. | Contact | (301) 215-0785 | bernadette.redd@nih.gov |
| Name | Affiliation | Role |
|---|---|---|
| Bernadette A Redd, M.D. | National Institutes of Health Clinical Center (CC) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Institutes of Health Clinical Center | Recruiting | Bethesda | Maryland | 20892 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 7862963 | Background | Mattay VS, Weinberger DR, Barrios FA, Sobering GS, Kotrla KJ, van Gelderen P, Duyn JH, Sexton RH, Moonen CT, Frank JA. Brain mapping with functional MR imaging: comparison of gradient-echo--based exogenous and endogenous contrast techniques. Radiology. 1995 Mar;194(3):687-91. doi: 10.1148/radiology.194.3.7862963. | |
| 19188312 | Background |
| Label | URL |
|---|---|
| NIH Clinical Center Detailed Web Page | View source |
Not provided
We are working on deciding if we want to share IPD.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Perez-Rodriguez J, Lai S, Ehst BD, Fine DM, Bluemke DA. Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases. Radiology. 2009 Feb;250(2):371-7. doi: 10.1148/radiol.2502080498. |
| 7928216 | Background | Frank JA, Mattay VS, Duyn J, Sobering G, Barrios FA, Zigun J, Sexton R, Kwok P, Woo J, Moonen C, et al. Measurement of relative cerebral blood volume changes with visual stimulation by 'double-dose' gadopentetate-dimeglumine-enhanced dynamic magnetic resonance imaging. Invest Radiol. 1994 Jun;29 Suppl 2:S157-60. doi: 10.1097/00004424-199406001-00052. No abstract available. |
| 26695065 | Derived | Ahlman MA, Raman FS, Penzak SR, Pang J, Fan Z, Liu S, Gai N, Li D, Bluemke DA. Part 1 - Coronary angiography with gadofosveset trisodium: a prospective feasibility study evaluating injection techniques for steady-state imaging. BMC Cardiovasc Disord. 2015 Dec 22;15:177. doi: 10.1186/s12872-015-0176-0. |
| 23515949 | Derived | Raman FS, Nacif MS, Cater G, Gai N, Jones J, Li D, Sibley CT, Liu S, Bluemke DA. 3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium. Int J Cardiovasc Imaging. 2013 Jun;29(5):1085-94. doi: 10.1007/s10554-013-0192-z. Epub 2013 Mar 21. |